Untargeted metabolomics profiling of gestational diabetes mellitus: insights into early diagnosis and metabolic pathway alterations
IntroductionGestational Diabetes Mellitus (GDM) is a metabolic disorder marked by Q10 hyperglycemia that can negatively affect both mothers and newborns. The increasing prevalence of GDM and the limitations associated with the standard diagnostic test highlight the urgent need for early screening st...
        Saved in:
      
    
          | Main Authors: | Shereen M. Aleidi, Hiba Al Fahmawi, Reem H. AlMalki, Maha Al Mogren, Mohammad Alwahsh, Muhammad Mujammami, Michele Costanzo, Anas Abdel Rahman | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | Frontiers Media S.A.
    
        2024-12-01 | 
| Series: | Frontiers in Molecular Biosciences | 
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2024.1485587/full | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    Untargeted metabolomics reveal the corrective effects of scorpion on epileptic mice        
                          
 by: Lele Li, et al.
 Published: (2025-01-01)
- 
                
                    Effect of Methylation on Storage Properties of Lacticaseibacillus paracasei as Analyzed by Untargeted Metabolomics        
                          
 by: YOU Mingkun, ZHANG Wenyi
 Published: (2025-01-01)
- 
                
                    The formation pathway of flavor compounds in steamed Antarctic krill (Euphausia superba) based on untargeted metabolomics        
                          
 by: Tingting Yang, et al.
 Published: (2025-01-01)
- 
                
                    Untargeted metabolomics profiling for the geographical authentication of traditional pempek using high-resolution orbitrap mass spectrometry        
                          
 by: Agus Supriadi, et al.
 Published: (2025-03-01)
- 
                
                    Untargeted metabolomic and proteomic analysis implicates SIRT2 as a novel therapeutic target for diabetic nephropathy        
                          
 by: Ruijing Zhang, et al.
 Published: (2025-02-01)
 
       